High-risk Brugada syndrome: factors associated with arrhythmia recurrence and benefits of epicardial ablation in addition to implantable cardioverter defibrillator implantationVincenzo Santinelli, Carlo Pappone, Giuseppe Ciconte et al.|EP Europace|2023Cited by 24
NaV1.5 autoantibodies in Brugada syndrome: pathogenetic implicationsAdriana Tarantino, Carlo Pappone, Giuseppe Ciconte et al.|European Heart Journal|2024Cited by 22
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trialCarlo Pappone, Luigi Anastasia, Pasquale Creo et al.|EP Europace|2025Cited by 10
Anatomical-guided third-generation laser balloon ablation for the treatment of paroxysmal atrial fibrillation assessed by continuous rhythm monitoring: results from a multicentre prospective studyGiuseppe Ciconte, Carlo Pappone, Marco Schiavone et al.|EP Europace|2024Cited by 7
Challenges in Brugada Syndrome Stratification: Investigating SCN5A Mutation Localization and Clinical PhenotypesAdriana Tarantino, Carlo Pappone, Giuseppe Ciconte et al.|International Journal of Molecular Sciences|2023Cited by 5